{"id":"placebo-to-l50-h12-5","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL6068498","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The designation 'Placebo to L50/H12.5' indicates this is a phase 3 trial arm where patients receive placebo, likely with the intent to transition or compare to an active treatment containing L50 and H12.5 components. Without identification of the specific active compounds, the precise mechanism cannot be determined.","oneSentence":"This is a placebo control arm in a clinical trial comparing a fixed-dose combination of L50/H12.5 against placebo.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:28:38.319Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT01307033","phase":"PHASE3","title":"A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-03-29","conditions":"Hypertension","enrollment":278},{"nctId":"NCT01302691","phase":"PHASE3","title":"MK-0954E Study in Participants With Hypertension (MK-0954E-357)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2011-01-01","conditions":"Hypertension","enrollment":327},{"nctId":"NCT01299376","phase":"PHASE3","title":"MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2011-01-24","conditions":"Hypertension","enrollment":286}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo to L50/H12.5","genericName":"Placebo to L50/H12.5","companyName":"Merck Sharp & Dohme LLC","companyId":"merck","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}